Webinars
Previous Webinars
Improving Preclinical Study Accuracy Using PDX with Next-Gen Multiomic Datasets
Presented by Stefano Cairo, PhD, Senior Global Scientific Director at Champions Oncology
The Omic Revolution: Leveraging Deep Multiomic Integration to Illuminate Cellular Dynamics
Presented by Michael Ritchie, PhD, MBA, CCO at Champions Oncology
Novel Applications for Ex-Vivo PDX Models of the Tumor Microenvironment
Translational Oncology Virtual Summit held in September 2020
Presented by Veronica Sacchi, PhD, Scientist III, PhenoVista Biosciences
Embracing Variation: A Multi-Batch Study Delivers Robust Estimates of Efficacy
Translational Oncology Virtual Summit held in September 2020
Presented by Natasha A Karp, PhD, Principal Biostatistician in Discovery Sciences, AstraZeneca
Fast-Tracking C010DS-Zn: PARP1-agonist Targeting Cancer and M2-like Macrophages
Translational Oncology Virtual Summit held in September 2020
Presented by Jinhyuk Fred Chung, PhD, Chief Scientific Officer, Xylonix Pte. Ltd.
High-Definition Spatial Proteomics for Characterizing the Tumor Microenvironment
Translational Oncology Virtual Summit held in September 2020
Presented by Jason Ptacek, PhD, Associate Director of Research Services, IONpath, Inc.
Selective Ablation of Malignant Cells Using Apoptotic Gene Therapy
Translational Oncology Virtual Summit held in September 2020
Presented by Jailal Ablack, PhD, Head of Preclinical Research, OncoSenX
Evaluation of Acute Myeloid Leukemia by High Parameter Flow Cytometry
Translational Oncology Virtual Summit held in September 2020
Presented by Greg Bannish, PhD, Flow Cytometry Subject Matter Expert, Champions Oncology
Targeting IDH Mutations in Cancer
Translational Oncology Virtual Summit held in September 2020
Presented by Brandon Nicolay, PhD, Associate Director, Pharmacology, Agios Pharmaceuticals
Human-Derived IO Preclinical Systems - From In Vitro to In Vivo and Back
Translational Oncology Virtual Summit held in September 2020
Presented by Amy Wesa, PhD, Head of R&D, Champions Oncology
Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck SCCs
Translational Oncology Virtual Summit held in September 2020
Presented by Francis Burrows, PhD, VP of Translational Research, Kura Oncology
Models for Evaluating Cancerous Stem Cell-Targeting Therapeutics
Translational Oncology Virtual Summit held in September 2020
Presented by Lynn Biderman, PhD, Senior Scientist, Stelexis Therapeutics
Constrained Bicyclic Peptide Delivery of Toxin & Immune-agonists to Solid Tumors
Translational Oncology Virtual Summit held in September 2020
Presented by Johanna Lahdenranta, PhD, Director, In Vivo Pharmacology, Bicycle Therapeutics
Cell Cycle Intervention Beyond Palbociclib; Discovery of a CDK2/4/6 Inhibitor
Translational Oncology Virtual Summit held in September 2020
Presented by Stephen Dann, PhD, Associate Research Fellow, Pfizer
Targeting Notch Altered Patient Derived Xenografts (PDX) with AL101
Translational Oncology Virtual Summit held in September 2020
Presented by Joel Kaye, PhD, VP Research & Nonclinical Development, Ayala Pharmaceuticals
Novel Applications for Ex Vivo PDX Models of the Tumor Microenvironment
Presented by Chris Koehler, PhD, Director of Scientific Operations at PhenoVista Biosciences
Myeloid Cell Conundrum in Inflammation and Cancer
Presented by Pravesh Gupta,PhD, Postdoctoral Fellow at Krishna Bhat's Lab at MD Anderson
LUMIN: Harnessing the Power of Pharmaco-omics to Illuminate Tumor Cell Biology
Presented by Michael Ritchie, PhD, MBA, Champions Oncology, Chief Commercial Officer
Flow Cytometry: Validation and Implementation in a Regulatory Setting
Presented by Chelsea Riveley, MBA, Head of Business Development, Flow Cytometry Services
It’s In The Blood: Patient-Derived Hematologic Malignancy Models in Research
Presented by Amy Wesa, PhD, Director of Immuno-Oncology Research, Champions Oncology
Designing Cytometry Assays for Immuno-Oncology Applications: The Do’s, Don’ts & Don’t Forgets
Presented by Dr. Tamara Laskowski, Senior Research Scientist of MD Anderson Cancer Center
Next Generation Humanized Mice for AML and NK Cell Therapy Testing
Presented by Amy Wesa, PhD, Director of Immuno-Oncology Research
Advanced Hematology Oncology PDX Tumor Biology Platforms for Drug Advancement
Presented by Neal Goodwin, PhD, Vice President of Research Development
PDX Programs for Clinical Advancement of Oncology Agents
Presented by Neal Goodwin, PhD, Vice President of Research Development
Modeling the Human Immune System for Immuno-Oncology Drug Development
A Taconic Biosciences Webinar Series
